| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/1999 | EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 11/24/1999 | EP0957891A1 Reduction of hair growth |
| 11/24/1999 | EP0957887A2 Composition and method for reducing stinging in skin |
| 11/24/1999 | EP0957806A1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (E h?) LEVELS |
| 11/24/1999 | EP0892632A4 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 11/24/1999 | EP0845045A4 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 11/24/1999 | EP0808165A4 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
| 11/24/1999 | EP0805790B1 Improved synthesis of cyclopropylacetylene |
| 11/24/1999 | EP0739205B1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections |
| 11/24/1999 | EP0662836B1 Germicidal detergent-iodine compositions having reduced detergent content |
| 11/24/1999 | EP0650366B1 Compositions and methods for treating wounds |
| 11/24/1999 | EP0643692B1 High cis beta-carotene composition |
| 11/24/1999 | EP0633893B1 17-substituted steroids useful in cancer treatment |
| 11/24/1999 | EP0627419B1 Optically active 1-phenylpyrrolidone derivative and preparation thereof |
| 11/24/1999 | EP0495091B1 Aica riboside analogs |
| 11/24/1999 | CN1236369A New Knoevenagel condensation products, method for their production and use |
| 11/24/1999 | CN1236367A Benzonaphthyrindines as bronchial therapeutics |
| 11/24/1999 | CN1236366A Amino acid ester containing azole antifungals |
| 11/24/1999 | CN1236365A Substituted benzocycloheptapyridine useful as inhibitors of Farnesyl protein transferase |
| 11/24/1999 | CN1236364A Substituted benzocycloheptapyridine derivatives useful for inhibition of Farnesyl protein transferase |
| 11/24/1999 | CN1236362A Azinyloxy- and phenoxy-diaryl-carboxylic derivatives, their preparation and use as mixed ET/ET encothelin receptor |
| 11/24/1999 | CN1236361A N-substituted 2-cyanopyrodlidines |
| 11/24/1999 | CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
| 11/24/1999 | CN1236358A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 11/24/1999 | CN1236356A Novel ethylamine derivatives |
| 11/24/1999 | CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 11/24/1999 | CN1236320A Therapeutic uses of BPI protein products for human meningococcemia |
| 11/24/1999 | CN1236319A Pharmaceutical composition containing a mixed extract of phellodondron amurense amurense ruprecht cortex and patrinia scabiosaefolia fish for treatment of hepatitis C |
| 11/24/1999 | CN1236318A Method for treating bronchitis with uridine triphosphates and related compounds |
| 11/24/1999 | CN1236317A Stable aspirin ointment preparations |
| 11/24/1999 | CN1236316A Stable aspirin-containing preparations for external use |
| 11/24/1999 | CN1236315A A pharmaceutical composition containing kynurbenine and thymine or tryptopham and thymine |
| 11/24/1999 | CN1236314A Biocidal compositions |
| 11/24/1999 | CN1236313A Novel methods |
| 11/24/1999 | CN1236299A Method of treating post menopausal diseases, including osteoporosis |
| 11/24/1999 | CN1236012A Polycyclic antiparasitic agents, process and strain for their preparation and their use |
| 11/24/1999 | CN1235973A Sidechain-bearing taxanes |
| 11/24/1999 | CN1235968A Substituted tricyclics |
| 11/24/1999 | CN1235967A Carbazolone derivatives |
| 11/24/1999 | CN1235839A Chinese and Western medicinal preparation for curing hand and foot tinea |
| 11/24/1999 | CN1235833A Novel drug composition for treating and curing and its preparing method |
| 11/24/1999 | CN1235832A Compound chitosan |
| 11/24/1999 | CN1235831A Medicinal composition containing globoside and its use |
| 11/24/1999 | CN1235830A Medicine for curing brain dysfunction and epilepsy |
| 11/24/1999 | CN1235829A Composite containing vitamin B12 |
| 11/24/1999 | CN1235828A Diphosphonic acid derivative and pharmaceutical composition containing diphosphonic acid derivative used as bone fracture curing medicine |
| 11/24/1999 | CN1235827A Estradiol benzoate gel agent and its preparing method |
| 11/24/1999 | CN1235826A 10, 11 methanodibenzosuberane derivatives used as chemosensitizing agents |
| 11/24/1999 | CN1235824A Process for producing enteric coated pancreatin granules |
| 11/24/1999 | CN1235795A Anti-cellulite pantyhose |
| 11/24/1999 | CN1046736C 'Delta' 16 unsaturated and (1) heterocyclic steroids useful s steroid (1)-20 lyase inhibitors |
| 11/24/1999 | CN1046735C Steroids for treating menopausal complaints |
| 11/24/1999 | CN1046734C Process for producing sugar ester matter containing gangliosides as major matter |
| 11/24/1999 | CN1046733C Phosphonic diester derivatives |
| 11/24/1999 | CN1046732C Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno [2,3-b] thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 11/24/1999 | CN1046731C Pyrrolo [2,3-d] pyrimidines and their use |
| 11/24/1999 | CN1046727C HIV protease inhibitors |
| 11/24/1999 | CN1046726C Imidazopyridine-pyrrolidone, its preparation and medical use |
| 11/24/1999 | CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use |
| 11/24/1999 | CN1046723C Tetracyclic compounds, pharmaceutical containing them and its use |
| 11/24/1999 | CN1046722C Heterocyclic compounds and their preparation and use |
| 11/24/1999 | CN1046721C Heterocyclic compounds and their preparation and use |
| 11/24/1999 | CN1046720C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 11/24/1999 | CN1046718C 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2-adrenoceptor agonists |
| 11/24/1999 | CN1046715C Process for making HIV protease inhibitors |
| 11/24/1999 | CN1046714C Diaryloxazole derivatives and its preparing method use and pharmaceutical composition |
| 11/24/1999 | CN1046713C Tetrahydroisoquinoline compound, pharmaceutical composition containing them and its producing method and use |
| 11/24/1999 | CN1046712C Process for preparation of leukotriene antagonists |
| 11/24/1999 | CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 11/24/1999 | CN1046710C aminopyridines, process for preparing the same and use and medicaments containing the same |
| 11/24/1999 | CN1046700C Process for preparing diacetyl rhein |
| 11/24/1999 | CN1046633C Making process for compound melbine capsule |
| 11/24/1999 | CN1046632C Method for preparing injectable preparation containing cephalosporin medicament |
| 11/23/1999 | US5990329 Retinoids |
| 11/23/1999 | US5990328 Forming 4-nitro-3-ketosteroids which by nitration of the corresponding 3,5-dienolate, reduction of 4-nitro-3-ketosteroid forms 4-amino-3-ketosteroid |
| 11/23/1999 | US5990326 An antiinflammatory agent as inhibitors of leukotriene hydrolase |
| 11/23/1999 | US5990314 Pharmaceutical pyridine compounds |
| 11/23/1999 | US5990299 Control of CD44 gene expression for therapeutic use |
| 11/23/1999 | US5990285 Catalytic antibodies against cocaine |
| 11/23/1999 | US5990241 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 11/23/1999 | US5990178 Administering to poultry an effective amount of at least one member selected from thymol and carvacrol |
| 11/23/1999 | US5990177 Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway |
| 11/23/1999 | US5990176 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 11/23/1999 | US5990175 Prevention of migraine |
| 11/23/1999 | US5990173 Anticholesterol agents; treating atherosclerosis; enzyme inhibitors of acylcoenzyme a:cholesterol acyltransferase (acat) |
| 11/23/1999 | US5990172 Peptidomimetics for the treatment of HIV infection |
| 11/23/1999 | US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders |
| 11/23/1999 | US5990169 Bone morphogenetic factors, anti-resorptive agents, osteogenic factors, cartilage-derived morphogenic proteins, growth hormones and differentiating factors; bone disorders; fractures; compounds of two aromatic systems covalently linked |
| 11/23/1999 | US5990168 Administering one or more prostaglandins, preferably pge2; diagnostic radioimaging by administrating the pg followed by irradiation; genetic disorders |
| 11/23/1999 | US5990167 Activity-inhibitor and activity-potentiator for glutamic acid in the brain |
| 11/23/1999 | US5990165 Pharmaceutical compounds |
| 11/23/1999 | US5990164 Cardiovascular disorders, antidiabetic agents, skin diseases, antiinflammatory and -carcinogenic agents, immunological diseases, psychological and skin disorders; water soluble; nutrients; foods; topical |
| 11/23/1999 | US5990163 Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor |
| 11/23/1999 | US5990162 Method for treatment of fibromyalgia and chronic fatigue syndrome |
| 11/23/1999 | US5990160 In vitro testing of puberulic or puberulonic acid as enzyme inhibitors of inositol monophosphatase; antidepressants for depression and manic depression |
| 11/23/1999 | US5990159 Pharmaceutical formulations comprising a selective serotonin reuptake inhibitors and a 5ht4 receptor antagonists; reduction of gastrointestinal side effects |
| 11/23/1999 | US5990158 Carboxylic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 11/23/1999 | US5990156 Viricides for the influenza virus; neuraminidase inhibitors; also parainfluenza, mumps, newcastle disease virus and sendai virus; myxovirus |
| 11/23/1999 | US5990155 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 11/23/1999 | US5990153 Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury |